ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NeuroRx Reports Phase 2 Efficacy for NRX-101 americanpharmaceuticalreview
May 31, 2019NeuroRx announced statistically significant final results from its Phase 2 STABIL-B study of?NRX-101?versus lurasidone in patients with Severe Bipolar Depression and Acute Suicidal Ideation or Behavior (ASIB).
Pharma Sources Insight January 2025
